Literature DB >> 15113581

PAMPA--a drug absorption in vitro model 8. Apparent filter porosity and the unstirred water layer.

Per E Nielsen1, Alex Avdeef.   

Abstract

In the parallel artificial membrane permeability assay (PAMPA), if more lipid is used than needed to fill all the pores of a microfilter, the excess lipid layer on both sides of the lipophilic filter increases the "apparent" porosity, epsilon(a), of the filter. The specific resistance of the artificial membrane barrier is lowered with increasing lipid excess. If this effect is not recognized, and the uncorrected value of filter porosity, epsilon, is used, then the calculated intrinsic permeability and the unstirred water layer (UWL) permeability coefficient of the permeating molecule can be significantly overestimated, resulting in underestimates of the thickness of the unstirred water layer. Unstirred water layer corrections are important in pharmaceutical research for in vitro-in vivo correlations aimed at predicting oral absorption and blood-brain barrier penetration characteristics of lead candidate compounds. The novel concept of the apparent porosity is introduced, described, and its utility demonstrated with the drugs diclofenac, desipramine, caffeine, and piroxicam. The PAMPA data of Wohnsland and Faller [J. Med. Chem. 44 (2001) 923] is taken as an example, where the reported extraordinarily efficient stirring is thought to be better explained in terms of normal stirring when apparent porosity is taken into account in the calculation of the effective permeability coefficient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113581     DOI: 10.1016/j.ejps.2004.02.003

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  11 in total

Review 1.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 2.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

3.  The asymmetry of the unstirred water layer in permeability experiments.

Authors:  Timo Korjamo; Aki T Heikkinen; Pekka Waltari; Jukka Mönkkönen
Journal:  Pharm Res       Date:  2008-04-16       Impact factor: 4.200

4.  PAMPA - excipient classification gradient map.

Authors:  Stefanie Bendels; Oksana Tsinman; Björn Wagner; Dana Lipp; Isabelle Parrilla; Manfred Kansy; Alex Avdeef
Journal:  Pharm Res       Date:  2006-10-20       Impact factor: 4.200

5.  Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules.

Authors:  Cameron R Pye; William M Hewitt; Joshua Schwochert; Terra D Haddad; Chad E Townsend; Lyns Etienne; Yongtong Lao; Chris Limberakis; Akihiro Furukawa; Alan M Mathiowetz; David A Price; Spiros Liras; R Scott Lokey
Journal:  J Med Chem       Date:  2017-01-25       Impact factor: 7.446

6.  Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.

Authors:  Oksana Tsinman; Konstantin Tsinman; Na Sun; Alex Avdeef
Journal:  Pharm Res       Date:  2010-10-14       Impact factor: 4.200

7.  Sequence-Dependent Interfacial Adsorption and Permeation of Dipeptides across Phospholipid Membranes.

Authors:  Chenyu Wei; Andrew Pohorille
Journal:  J Phys Chem B       Date:  2017-10-16       Impact factor: 2.991

8.  A novel screening strategy to identify ABCB1 substrates and inhibitors.

Authors:  Oliver von Richter; Hristos Glavinas; Peter Krajcsi; Stephanie Liehner; Beate Siewert; Karl Zech
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-29       Impact factor: 3.000

9.  Maintaining the Constant Exposure Condition for an Acute Caenorhabditis elegans Mortality Test Using Passive Dosing.

Authors:  Hyuck-Chul Kwon; Ji-Yeon Roh; Dongyoung Lim; Jinhee Choi; Jung-Hwan Kwon
Journal:  Environ Health Toxicol       Date:  2011-10-25

10.  Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations.

Authors:  Oliver J Hedge; Christel A S Bergström
Journal:  Pharm Res       Date:  2020-05-20       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.